Trending Now
Exelixis Inc. (NASDAQ:EXEL) Commences Phase 3 CONTACT-01 Evaluating Combination of Cabozantinib...
Exelixis Inc. (NASDAQ:EXEL) has announced the start of the third phase vital CONTACT-01 cabozantinib (CABOMETYX) study combined with atezolizumab in metastatic non-small cell lung...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Zafgen Inc. (NASDAQ:ZFGN) Announces Reverse Merger With Chondrial Therapeutics With New...
Zafgen Inc. (NASDAQ:ZFGN) and Chondrial Therapeutics Inc. have announced the finalization of a reverse merger transaction forming a new public company. The combined biotechnology...
MAKE IT MODERN
LATEST REVIEWS
Aytu Bioscience Inc (NASDAQ:AYTU) Reports An Impressive Fiscal Q4 2020 Performance
Aytu Bioscience Inc (NASDAQ:AYTU) recently released its financial report for its fiscal Q4 2020 ended June 30, 2020, revealing impressive financial highlights.
The company’s net...
MAKE IT MODERN
PERFORMANCE TRAINING
Sorrento Therapeutics Inc‘s (NASDAQ: SRNE) Subsidiary Scilex Holdings Signs Term Sheet To acquire Ancora...
Sorrento Therapeutics Inc's (NASDAQ: SRNE) almost 100% owned subsidiary Scilex Holding Company has signed a term sheet to purchase privately-held medical tech firm Ancora...
ANEW Medical’s (WENA) Breakthrough in Gene Therapy Leads To Surge in Stock Prices
In the bustling landscape of biopharmaceutical innovations, ANEW Medical Inc. (NASDAQ: WENA) stands out with its pioneering strides in the realm of...
The US FDA Allows Sorrento Therapeutics Inc (NASDAQ:SRNE) To Conduct Phase 2a Clinical Study...
Sorrento Therapeutics Inc (NASDAQ:SRNE) and its partners advanced fully human mABs (monoclonal antibodies) into clinical development to treat cancers and COVID-19.
Sorrento’s CEO, Henry Ji,...
Tesla Inc (NASDAQ: TSLA) looks primed for a bounce and here’s why
It’s not often that Tesla Inc (NASDAQ: TSLA) gets oversold. The RSI is currently below the 30 line and it could be...
CERo Therapeutics Holdings, Inc. (CERO): 173% Stock Surge Driven by Promising Preclinical Data for...
CERo Therapeutics Holdings, Inc. (Nasdaq: CERO), an innovative immunotherapy company specializing in next-generation T cell therapeutics, witnessed an extraordinary 173% surge in...
MAKE IT MODERN
